Cargando…

IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection

BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Hong, Sun, Chenglu, Zhu, Yanglin, Qin, Yafei, Ren, Shaohua, Wang, Zhaobo, Li, Chuan, Li, Xiang, Zhang, Baoren, Hao, Jingpeng, Li, Guangming, Wang, Hongda, Shao, Bo, Zhang, Jingyi, Wang, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284885/
https://www.ncbi.nlm.nih.gov/pubmed/35841010
http://dx.doi.org/10.1186/s13287-022-02982-1
_version_ 1784747662421000192
author Qin, Hong
Sun, Chenglu
Zhu, Yanglin
Qin, Yafei
Ren, Shaohua
Wang, Zhaobo
Li, Chuan
Li, Xiang
Zhang, Baoren
Hao, Jingpeng
Li, Guangming
Wang, Hongda
Shao, Bo
Zhang, Jingyi
Wang, Hao
author_facet Qin, Hong
Sun, Chenglu
Zhu, Yanglin
Qin, Yafei
Ren, Shaohua
Wang, Zhaobo
Li, Chuan
Li, Xiang
Zhang, Baoren
Hao, Jingpeng
Li, Guangming
Wang, Hongda
Shao, Bo
Zhang, Jingyi
Wang, Hao
author_sort Qin, Hong
collection PubMed
description BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression can enhance the therapeutic effects of ERCs in inhibition of acute cardiac allograft rejection remains unknown and will be explored in this study. METHODS: C57BL/6 mice recipients receiving BALB/c mouse heterotopic heart allografts were randomly divided into the phosphate-buffered saline (untreated), ERC treated, negative lentiviral control ERC (NC-ERC) treated, and IL-37 overexpressing ERC (IL-37-ERC) treated groups. Graft pathological changes were assessed by H&E staining. The intra-graft cell infiltration and splenic immune cell populations were analyzed by immunohistochemistry and flow cytometry, respectively. The stimulatory property of recipient DCs was tested by an MLR assay. Furthermore, serum cytokine profiles of recipients were measured by ELISA assay. RESULTS: Mice treated with IL-37-ERCs achieved significantly prolonged allograft survival compared with the ERC-treated group. Compared with all the other control groups, IL-37-ERC-treated group showed mitigated inflammatory response, a significant increase in tolerogenic dendritic cells (Tol-DCs), regulatory T cells (Tregs) in the grafts and spleens, while a reduction of Th1 and Th17 cell population. Additionally, there was a significant upregulation of immunoregulatory IL-10, while a reduction of IFN-γ, IL-17A, IL-12 was detected in the sera of IL-37-ERC-treated recipients. CONCLUSION: IL-37 overexpression can promote the therapeutic effects of ERCs to inhibit acute allograft rejection and further prolong graft survival. This study suggests that gene-modified ERCs overexpressing IL-37 may pave the way for novel therapeutic options in the field of transplantation.
format Online
Article
Text
id pubmed-9284885
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92848852022-07-16 IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection Qin, Hong Sun, Chenglu Zhu, Yanglin Qin, Yafei Ren, Shaohua Wang, Zhaobo Li, Chuan Li, Xiang Zhang, Baoren Hao, Jingpeng Li, Guangming Wang, Hongda Shao, Bo Zhang, Jingyi Wang, Hao Stem Cell Res Ther Research BACKGROUND: Endometrial regenerative cells (ERCs) play an important role in attenuation of acute allograft rejection, while their effects are limited. IL-37, a newly discovered immunoregulatory cytokine of the IL-1 family, can regulate both innate and adaptive immunity. Whether IL-37 overexpression can enhance the therapeutic effects of ERCs in inhibition of acute cardiac allograft rejection remains unknown and will be explored in this study. METHODS: C57BL/6 mice recipients receiving BALB/c mouse heterotopic heart allografts were randomly divided into the phosphate-buffered saline (untreated), ERC treated, negative lentiviral control ERC (NC-ERC) treated, and IL-37 overexpressing ERC (IL-37-ERC) treated groups. Graft pathological changes were assessed by H&E staining. The intra-graft cell infiltration and splenic immune cell populations were analyzed by immunohistochemistry and flow cytometry, respectively. The stimulatory property of recipient DCs was tested by an MLR assay. Furthermore, serum cytokine profiles of recipients were measured by ELISA assay. RESULTS: Mice treated with IL-37-ERCs achieved significantly prolonged allograft survival compared with the ERC-treated group. Compared with all the other control groups, IL-37-ERC-treated group showed mitigated inflammatory response, a significant increase in tolerogenic dendritic cells (Tol-DCs), regulatory T cells (Tregs) in the grafts and spleens, while a reduction of Th1 and Th17 cell population. Additionally, there was a significant upregulation of immunoregulatory IL-10, while a reduction of IFN-γ, IL-17A, IL-12 was detected in the sera of IL-37-ERC-treated recipients. CONCLUSION: IL-37 overexpression can promote the therapeutic effects of ERCs to inhibit acute allograft rejection and further prolong graft survival. This study suggests that gene-modified ERCs overexpressing IL-37 may pave the way for novel therapeutic options in the field of transplantation. BioMed Central 2022-07-15 /pmc/articles/PMC9284885/ /pubmed/35841010 http://dx.doi.org/10.1186/s13287-022-02982-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Qin, Hong
Sun, Chenglu
Zhu, Yanglin
Qin, Yafei
Ren, Shaohua
Wang, Zhaobo
Li, Chuan
Li, Xiang
Zhang, Baoren
Hao, Jingpeng
Li, Guangming
Wang, Hongda
Shao, Bo
Zhang, Jingyi
Wang, Hao
IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title_full IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title_fullStr IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title_full_unstemmed IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title_short IL-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
title_sort il-37 overexpression promotes endometrial regenerative cell-mediated inhibition of cardiac allograft rejection
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9284885/
https://www.ncbi.nlm.nih.gov/pubmed/35841010
http://dx.doi.org/10.1186/s13287-022-02982-1
work_keys_str_mv AT qinhong il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT sunchenglu il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT zhuyanglin il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT qinyafei il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT renshaohua il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT wangzhaobo il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT lichuan il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT lixiang il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT zhangbaoren il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT haojingpeng il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT liguangming il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT wanghongda il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT shaobo il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT zhangjingyi il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection
AT wanghao il37overexpressionpromotesendometrialregenerativecellmediatedinhibitionofcardiacallograftrejection